15 results
dm2 endocrinology summary inhibitors dosing metformin agonists comparison dpp4 glp1 management medications sglt2 sideeffects adverse adverseeffects algorithm antipsychotics atypical binder
Summary table of mechanism of action, side effect and contraindications of commonly used diabetic drugs. #pharmacology
mechanism of action, side ... commonly used diabetic ... #pharmacology #dm2 ... #diabetes #medications
TACROLIMUS - Side Effects Mnemonic Tremor Alopecia Cardiovascular (HTN) Renal insufficiency Oncologic (Skin Cancer) Lipids (hyperlipidemia) Insulin
TACROLIMUS - Side ... Insulin dependent diabetes ... Seizures #Pharmacology
Sulfonylureas - Pharmacology Summary Mechanisms of Action: Binds to the ATP-sensitive potassium channel in pancreatic beta cells,
Sulfonylureas - Pharmacology ... in CKD Common Side ... Sulfonylureas #Pharmacology ... #Summary #DM2 #diabetes
SGLT2 Inhibitors - Pharmacology Summary Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors - Pharmacology ... of use) Common Side ... • Euglycemic diabetic ... SGLT2 #Inhibitors #Pharmacology ... #Summary #DM2 #diabetes
SGLT2 Inhibitors SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
class of anti-diabetic ... drugs include side ... Side effects include ... SGLT2 #Inhibitors #Pharmacology ... Medications #DM2 #Diabetes
Metformin: Biguanide Metformin is the first-line medication for treatment of type 2 diabetes. It is very effective
treatment of type 2 diabetes ... counseling point for side ... is a potential side ... #Metformin #Pharmacology ... #Mechanism #Diabetes
Metformin Pharmacology Summary Mechanisms of Action: • Suppresses gluconeogenesis by the liver • Increases insulin-mediated glucose utilization
Metformin Pharmacology ... disease Common Side ... Toxicities: • GI side ... #Metformin #Pharmacology ... #Summary #DM2 #diabetes
Algorithm for Metformin Prescribing and Dosing in CKD Dose Initiation - Immediate release: • Initial 500 mg
release: • If Gl side ... #Dosing #CKD #pharmacology ... #algorithm #diabetes
GLP-1 Receptor Agonists - Pharmacology Summary Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
Receptor Agonists - Pharmacology ... pancreatitis Common Side ... Toxicities: • Gl side ... Receptor #Agonists #Pharmacology ... #Summary #DM2 #diabetes
DPP-4 Inhibitors - Pharmacology Summary Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
4 Inhibitors - Pharmacology ... failure Common Side ... DPP4 #Inhibitors #Pharmacology ... #Summary #DM2 #diabetes
No results found for "Wide pocus pharmacology pulmonaryembolism diabetes"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #Wide #pocus #pharmacology #pulmonaryembolism #diabetes